Krüppel-like factors 4 and 5: Unity in diversity

Current Genomics

Volumn 10, Issue 8, 2009, Pages 594-603

  Sur, Inderpreet ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; K RAS PROTEIN; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR 5; PLATELET DERIVED GROWTH FACTOR; SUMO PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADIPOCYTE; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; DEVELOPMENTAL STAGE; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EPIDERMIS CELL; GENE ACTIVITY; GENE OVEREXPRESSION; HUMAN; NONHUMAN; PROTEIN MODIFICATION; REVIEW; TRANSCRIPTION REGULATION;

EID: 73349127757     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920209789503932     Document Type: Review

References (98)

1. Wieschaus, E.; Nusslein-Volhard, C.; Kluding, H. Krüppel, a gene whose activity is required early in the zygotic genome for normal embryonic segmentation. Dev. Biol., 1984, 104, 172-186.
2. Ghaleb, A.M.; Nandan, M.O.; Chanchevalap, S.; Dalton, W.B.; Hisamuddin, I.M.; Yang, V.W. Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res., 2005, 15, 92-96.
3. Kaczynski, J.; Cook, T.; Urrutia, R. Sp1- and Krüppel-like transcription factors. Genome Biol., 2003, 4, 206.
4. Pearson, R.; Fleetwood, J.; Eaton, S.; Crossley, M.; Bao, S. Krüppel-like transcription factors: a functional family. Int. J. Biochem. Cell Biol., 2008, 40, 1996-2001.
5. Shields, J. M.; Christy, R.J.; Yang, V.W. Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J. Biol. Chem., 1996, 271, 20009-20017.
6. Conkright, M.D.; Wani, M.A.; Anderson, K.P.; Lingrel, J.B. A gene encoding an intestinal-enriched member of the Krüppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Res., 1999, 27, 1263-1270.
7. Segre, J.A.; Bauer, C.; Fuchs, E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet., 1999, 22, 356-360.
8. Ohnishi, S.; Laub, F.; Matsumoto, N.; Asaka, M.; Ramirez, F.; Yoshida, T.; Terada, M. Developmental expression of the mouse gene coding for the Krüppel-like transcription factor KLF5. Dev. Dyn., 2000, 217, 421-429.
9. Shi, H.; Zhang, Z.; Wang, X.; Liu, S.; Teng, C.T. Isolation and characterization of a gene encoding human Krüppel-like factor 5 (IKLF): binding to the CAAT/GT box of the mouse lactoferrin gene promoter. Nucleic Acids Res., 1999, 27, 4807-4815.
10. Sur, I.; Unden, A.B.; Toftgard, R. Human Krüppel-like factor5/ KLF5: synergy with NF- B/Rel factors and expression in human skin and hair follicles. Eur. J. Cell Biol., 2002, 81, 323-334.
11. Wassmann, S.; Wassmann, K.; Jung, A.; Velten, M.; Knuefermann, P.; Petoumenos, V.; Becher, U.; Werner, C. Mueller, C.; Nickenig, G. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J. Mol. Cell Cardiol., 2007, 43, 301-307.
12. Klaewsongkram, J.; Yang, Y.; Golech, S.; Katz, J.; Kaestner, K.H.; Weng, N.P. Krüppel-like factor 4 regulates B cell number and activation-induced B cell proliferation. J. Immunol., 2007, 179, 4679-4684.
13. Yusuf, I.; Kharas, M.G.; Chen, J.; Peralta, R.Q.; Maruniak, A.; Sareen, P.; Yang, V.W.; Kaestner, K.H.; Fruman, D.A. KLF4 is a FOXO target gene that suppresses B cell proliferation. Int. Immunol., 2008, 20, 671-681.
14. Yamada, T.; Park, C.S.; Mamonkin, M.; Lacorazza, H.D. Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Krüppel-like factors KLF4 and KLF2. Nat. Immunol., 2009, 10, 618-626.
15. Wei, D.; Kanai, M.; Jia, Z.; Le, X.; Xie, K. Krüppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res., 2008, 68, 4631-4639.
16. Chen, X.; Johns, D.C.; Geiman, D.E.; Marban, E.; Dang, D.T.; Hamlin, G.; Sun, R.; Yang, V.W. Krüppel-like factor 4 (gutenriched Kruppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J. Biol. Chem., 2001, 276, 30423-30428.
17. Shie, J.L.; Chen, Z.Y.; Fu, M.; Pestell, R.G.; Tseng, C.C. Gutenriched Krüppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res., 2000, 28, 2969-2976.
18. Sun, R.; Chen, X.; Yang, V.W. Intestinal-enriched Krüppel-like factor (Kruppel-like factor 5) is a positive regulator of cellular proliferation. J. Biol. Chem., 2001, 276, 6897-6900.
19. Bateman, N.W.; Tan, D.; Pestell, R.G.; Black, J.D.; Black, A.R. Intestinal tumor progression is associated with altered function of KLF5. J. Biol. Chem., 2004, 279, 12093-12101.
20. Nandan, M.O.; McConnell, B.B.; Ghaleb, A.M.; Bialkowska, A.B.; Sheng, H.; Shao, J.; Babbin, B.A.; Robine, S.; Yang, V.W. Krüppel-like factor 5 mediates cellular transformation during oncogenic KRAS-induced intestinal tumorigenesis. Gastroenterology, 2008, 134, 120-130.
21. Guo, P.; Dong, X.Y.; Zhang, X.; Zhao, K.W.; Sun, X.; Li, Q.; Dong, J.T. Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. J. Biol. Chem., 2009, 284, 6071-6078.
22. Chanchevalap, S.; Nandan, M.O.; Merlin, D.; Yang, V.W. All-trans retinoic acid inhibits proliferation of intestinal epithelial cells by inhibiting expression of the gene encoding Krüppel-like factor 5. FEBS Lett., 2004, 578, 99-105.
23. Rowland, B.D.; Bernards, R.; Peeper, D.S. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a contextdependent oncogene. Nat. Cell Biol., 2005, 7, 1074-1082. [24] Chen, C.; Bhalala, H.V.; Qiao, H.; Dong, J.T. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene, 2002, 21, 6567-6572.
24. Chen, C.; Bhalala, H.V.; Vessella, R.L.; Dong, J.T. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate, 2003, 55, 81-88.
25. Guo, P.; Zhao, K.W.; Dong, X.Y.; Sun, X.; Dong, J.T. Acetylation of KLF5 alters the assembly of P15 transcription factors in TGF -β mediated induction in epithelial cells. J. Biol. Chem., 2009, 284, 18184-18193.
26. Yang, Y.; Goldstein, B.G.; Chao, H.H.; Katz, J.P. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol. Ther., 2005, 4, 1216-1221.
27. Jaubert, J.; Cheng, J.; Segre, J.A. Ectopic expression of Krüppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier. Development, 2003, 130, 2767-2777.
28. Patel, S.; Xi, Z.F.; Seo, E.Y.; McGaughey, D.; Segre, J. A. Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition. Proc. Natl. Acad. Sci. USA, 2006, 103, 18668-18673.
29. Foster, K.W.; Liu, Z.; Nail, C.D.; Li, X.; Fitzgerald, T.J.; Bailey, S.K.; Frost, A.R.; Louro, I.D.; Townes, T.M.; Paterson, A.J.; Kudlow, J.E.; Lobo-Ruppert, S.M.; Ruppert, J.M. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene, 2005, 24, 1491-1500.
30. Katz, J.P.; Perreault, N.; Goldstein, B.G.; Lee, C.S.; Labosky, P.A.; Yang, V.W.; Kaestner, K.H. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development, 2002, 129, 2619-2628.
31. Swamynathan, S.K.; Katz, J.P.; Kaestner, K.H.; Ashery-Padan, R.; Crawford, M.A.; Piatigorsky, J. Conditional deletion of the mouse Klf4 gene results in corneal epithelial fragility, stromal edema, and loss of conjunctival goblet cells. Mol. Cell Biol., 2007, 27, 182-194.
32. Swamynathan, S.K.; Davis, J.; Piatigorsky, J. Identification of candidate Klf4 target genes reveals the molecular basis of the diverse regulatory roles of Klf4 in the mouse cornea. Invest. Ophthalmol. Vis. Sci., 2008, 49, 3360-3370.
33. Katz, J.P.; Perreault, N.; Goldstein, B.G.; Actman, L.; McNally, S.R.; Silberg, D.G.; Furth, E.E.; Kaestner, K.H. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology, 2005, 128, 935-945.
34. Godmann, M.; Katz, J.P.; Guillou, F.; Simoni, M.; Kaestner, K.H.; Behr, R. Krüppel-like factor 4 is involved in functional differentiation of testicular Sertoli cells. Dev. Biol., 2008, 315, 552-566.
35. Feinberg, M.W.; Wara, A.K.; Cao, Z.; Lebedeva, M.A.; Rosenbauer, F.; Iwasaki, H.; Hirai, H.; Katz, J.P.; Haspel, R.L.; Gray, S.; Akashi, K.; Segre, J.; Kaestner, K.H.; Tenen, D.G.; Jain, M.K. The Krüppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J., 2007, 26, 4138-4148.
36. Shindo, T.; Manabe, I.; Fukushima, Y.; Tobe, K.; Aizawa, K.; Miyamoto, S.; Kawai-Kowase, K.; Moriyama, N.; Imai, Y.; Kawakami, H.; Nishimatsu, H.; Ishikawa, T.; Suzuki, T.; Morita, H.; Maemura, K.; Sata, M.; Hirata, Y.; Komukai, M.; Kagechika, H.; Kadowaki, T.; Kurabayashi, M.; Nagai, R. Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat. Med., 2002, 8, 856-863.
37. Ema, M.; Mori, D.; Niwa, H.; Hasegawa, Y.; Yamanaka, Y.; Hitoshi, S.; Mimura, J.; Kawabe, Y.; Hosoya, T.; Morita, M.; Shimosato, D.; Uchida, K.; Suzuki, N.; Yanagisawa, J.; Sogawa, K.; Rossant, J.; Yamamoto, M.; Takahashi, S.; Fujii-Kuriyama, Y. Krüppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. Cell Stem Cell, 2008, 3, 555-567.
38. Oishi, Y.; Manabe, I.; Tobe, K.; Tsushima, K.; Shindo, T.; Fujiu, K.; Nishimura, G.; Maemura, K.; Yamauchi, T.; Kubota, N.; Suzuki, R.; Kitamura, T.; Akira, S.; Kadowaki, T.; Nagai, R. Krüppellike transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab., 2005, 1, 27-39.
39. Shinoda, Y.; Ogata, N.; Higashikawa, A.; Manabe, I.; Shindo, T.; Yamada, T.; Kugimiya, F.; Ikeda, T.; Kawamura, N.; Kawasaki, Y.; Tsushima, K.; Takeda, N.; Nagai, R.; Hoshi, K.; Nakamura, K.; Chung, U.I.; Kawaguchi, H. Krüppel-like factor 5 causes cartilage degradation through transactivation of matrix metalloproteinase 9. J. Biol. Chem., 2008, 283, 24682-24689.
40. Sur, I.; Rozell, B.; Jaks, V.; Bergstrom, A.; Toftgard, R. Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermis. J. Cell Sci., 2006, 119, 3593-3601.
41. Goldstein, B.G.; Chao, H.H.; Yang, Y.; Yermolina, Y.A.; Tobias, J.W.; Katz, J.P. Overexpression of Krüppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 292, G1784-G1792.
42. Wan, H.; Luo, F.; Wert, S.E.; Zhang, L.; Xu, Y.; Ikegami, M.; Maeda, Y.; Bell, S.M.; Whitsett, J. A. Krüppel-like factor 5 is required for perinatal lung morphogenesis and function. Development, 2008, 135, 2563-2572.
43. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126, 663-676.
44. Park, I.H.; Lerou, P.H.; Zhao, R.; Huo, H.; Daley, G.Q., Generation of human-induced pluripotent stem cells. Nat. Protoc., 2008, 3, 1180-1186.
45. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007, 131, 861-872.
46. Meissner, A.; Wernig, M.; Jaenisch, R., Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol., 2007, 25, 1177-1181.
47. Jiang, J.; Chan, Y.S.; Loh, Y.H.; Cai, J.; Tong, G.Q.; Lim, C.A.; Robson, P.; Zhong, S.; Ng, H.H. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nat. Cell. Biol., 2008, 10, 353-360.
48. Morris, R.J.; Liu, Y.; Marles, L.; Yang, Z.; Trempus, C.; Li, S.; Lin, J.S.; Sawicki, J.A.; Cotsarelis, G. Capturing and profiling adult hair follicle stem cells. Nat. Biotechnol., 2004, 22, 411-417.
49. Nguyen, H.; Rendl, M.; Fuchs, E. Tcf3 governs stem cell features and represses cell fate determination in skin. Cell, 2006, 127, 171-183.
50. Jaks, V.; Barker, N.; Kasper, M.; van Es, J. H.; Snippert, H. J.; Clevers, H.; Toftgard, R. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat. Genet., 2008, 40, 1291-1299.
51. Greco, V.; Chen, T.; Rendl, M.; Schober, M.; Pasolli, H. A.; Stokes, N.; Dela Cruz-Racelis, J.; Fuchs, E. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell, 2009, 4, 155-169.
52. D'Amour, K.A.; Gage, F.H. Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells. Proc. Natl. Acad. Sci. USA, 2003, 100, 11866-11872.
53. Natesampillai, S.; Kerkvliet, J.; Leung, P.C.; Veldhuis, J.D. Regulation of Krüppel-like factor 4, 9, and 13 genes and the steroidogenic genes LDLR, StAR, and CYP11A in ovarian granulosa cells. Am. J. Physiol. Endocrinol. Metab., 2008, 294, E385-E391.
54. Liu, J.; Zhang, H.; Liu, Y.; Wang, K.; Feng, Y.; Liu, M.; Xiao, X. KLF4 regulates the expression of interleukin-10 in RAW264.7 macrophages. Biochem. Biophys. Res. Commun., 2007, 362, 575-581.
55. Liu, Y.; Wang, J.; Yi, Y.; Zhang, H.; Liu, J.; Liu, M.; Yuan, C.; Tang, D.; Benjamin, I.J.; Xiao, X. Induction of KLF4 in response to heat stress. Cell Stress Chaperones, 2006, 11, 379-389.
56. Feinberg, M.W.; Cao, Z.; Wara, A.K.; Lebedeva, M.A.; Senbanerjee, S.; Jain, M.K. Krüppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J. Biol. Chem., 2005, 280, 38247-38258.
57. Chen, Z.Y.; Tseng, C.C. 15-deoxy-Delta12,14 prostaglandin J2 upregulates Krüppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Mol. Pharmacol., 2005, 68, 1203-1213.
58. Yoon, H.S.; Ghaleb, A.M.; Nandan, M.O.; Hisamuddin, I.M.; Dalton, W.B.; Yang, V.W. Krüppel-like factor 4 prevents centrosome amplification following -irradiation-induced DNA damage. Oncogene, 2005, 24, 4017-4025.
59. Mazzanti, C.M.; Tandle, A.; Lorang, D.; Costouros, N.; Roberts, D.; Bevilacqua, G.; Libutti, S.K. Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells. Genome Res., 2004, 14, 1585-1593.
60. King, K.E.; Iyemere, V.P.; Weissberg, P.L.; Shanahan, C.M. Krüppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor β 1 in the regulation of vascular smooth muscle cell phenotype. J. Biol. Chem., 2003, 278, 11661-11669.
61. Chen, Z.Y.; Shie, J.L.; Tseng, C.C. STAT1 is required for IFN- - mediated gut-enriched Krüppel-like factor expression. Exp. Cell Res., 2002, 281, 19-27.
62. Pidkovka, N.A.; Cherepanova, O.A.; Yoshida, T.; Alexander, M.R.; Deaton, R.A.; Thomas, J.A.; Leitinger, N.; Owens, G.K. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ. Res., 2007, 101, 792-801.
63. Yao, E.H.; Fukuda, N.; Ueno, T.; Tsunemi, A.; Endo, M.; Matsumoto, K. Complement 3 activates the KLF5 gene in rat vascular smooth muscle cells. Biochem Biophys. Res. Commun., 2008, 367, 468-473.
64. Munemasa, Y.; Suzuki, T.; Aizawa, K.; Miyamoto, S.; Imai, Y.; Matsumura, T.; Horikoshi, M.; Nagai, R. Promoter region-specific histone incorporation by the novel histone chaperone ANP32B and DNA-binding factor KLF5. Mol. Cell. Biol., 2008, 28, 1171-1181.
65. Zhang, H.; Bialkowska, A.; Rusovici, R.; Chanchevalap, S.; Shim, H.; Katz, J.P.; Yang, V.W.; Yun, C.C. Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5. J. Biol. Chem., 2007, 282, 15541-15549.
66. Gao, D.; Niu, X.; Ning, N.; Hao, G. Regulation of angiotensin IIInduced Krüppel-like factor 5 expression in vascular smooth muscle cells. Biol. Pharm. Bull, 2006, 29, 2004-2008.
67. Bafford, R.; Sui, X.X.; Wang, G.; Conte, M. Angiotensin II and tumor necrosis factor- upregulate survivin and Krüppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia. Surgery, 2006, 140, 289-296.
68. Chanchevalap, S.; Nandan, M.O.; McConnell, B.B.; Charrier, L.; Merlin, D.; Katz, J.P.; Yang, V.W. Krüppel-like factor 5 is an important mediator for lipopolysaccharide-induced proinflammatory response in intestinal epithelial cells. Nucleic Acids Res., 2006, 34, 1216-1223.
69. Usui, S.; Sugimoto, N.; Takuwa, N.; Sakagami, S.; Takata, S.; Kaneko, S.; Takuwa, Y. Blood lipid mediator sphingosine 1-phosphate potently stimulates platelet-derived growth factor-A and -B chain expression through S1P1-Gi-Ras-MAPK-dependent induction of Krüppel-like factor 5. J. Biol. Chem., 2004, 279, 12300-12311.
70. Lee, M.Y.; Moon, J.S.; Park, S.W.; Koh, Y.K.; Ahn, Y.H.; Kim, K.S. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells. Biochem. J., 2009, 417, 313-322.
71. Dong, J.T.; Chen, C. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol. Life Sci., 2009, 66, 2691-2706.
72. Evans, P.M.; Liu, C. Roles of Krüppel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim. Biophys Sin (Shanghai) 2008, 40, 554-564.
73. Chen, Z.Y.; Wang, X.; Zhou, Y.; Offner, G.; Tseng, C.C. Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway. Cancer Res., 2005, 65, 10394-10400.
74. Chen, C.; Sun, X.; Guo, P.; Dong, X.Y.; Sethi, P.; Cheng, X.; Zhou, J.; Ling, J.; Simons, J.W.; Lingrel, J.B.; Dong, J.T. Human Krüppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J. Biol. Chem., 2005, 280, 41553-41561.
75. Chen, C.; Sun, X.; Ran, Q.; Wilkinson, K.D.; Murphy, T.J.; Simons, J.W.; Dong, J.T. Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene, 2005, 24, 3319-3327.
76. Chen, C.; Zhou, Z.; Guo, P.; Dong, J. T. Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway. FEBS Lett., 2007, 581, 1124-1130.
77. Zhang, Z.; Teng, C. T. Phosphorylation of Krüppel-like factor 5 (KLF5/IKLF) at the CBP interaction region enhances its transactivation function. Nucleic Acids Res., 2003, 31, 2196-2208.
78. Evans, P.M.; Zhang, W.; Chen, X.; Yang, J.; Bhakat, K.K.; Liu, C. Krüppel-like factor 4 is acetylated by p300 and regulates gene transcription via modulation of histone acetylation. J. Biol. Chem., 2007, 282, 33994-34002.
79. Miyamoto, S.; Suzuki, T.; Muto, S.; Aizawa, K.; Kimura, A.; Mizuno, Y.; Nagino, T.; Imai, Y.; Adachi, N.; Horikoshi, M.; Nagai, R. Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol. Cell. Biol., 2003, 23, 8528-8541.
80. Kawai-Kowase, K.; Ohshima, T.; Matsui, H.; Tanaka, T.; Shimizu, T.; Iso, T.M.; Owens, G.K. Kurabayashi, M., PIAS1 mediates TGF -induced SM α-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation. Arterioscler. Thromb. Vasc. Biol., 2009, 29, 99-106.
81. Oishi, Y.; Manabe, I.; Tobe, K.; Ohsugi, M.; Kubota, T.; Fujiu, K.; Maemura, K.; Kubota, N.; Kadowaki, T.; Nagai, R. SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR- . Nat. Med., 2008, 14, 656-666.
82. Du, J.X.; Bialkowska, A.B.; McConnell, B.B.; Yang, V.W. SUMOylation regulates nuclear localization of Krüppel-like factor 5. J. Biol. Chem., 2008, 283, 31991-2002.
83. Zhao, W.; Hisamuddin, I. M.; Nandan, M. O.; Babbin, B. A.; Lamb, N. E.; Yang, V. W. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene, 2004, 23, 395-402.
84. Wei, D.; Gong, W.; Kanai, M.; Schlunk, C.; Wang, L.; Yao, J. C.; Wu, T.T.; Huang, S.; Xie, K. Drastic down-regulation of Krüppellike factor 4 expression is critical in human gastric cancer development and progression. Cancer Res., 2005, 65, 2746-2754.
85. Kanai, M.; Wei, D.; Li, Q.; Jia, Z.; Ajani, J.; Le, X.; Yao, J.; Xie, K. Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression. Clin. Cancer Res., 2006, 12, 6395-6402.
86. Ohnishi, S.; Ohnami, S.; Laub, F.; Aoki, K.; Suzuki, K.; Kanai, Y.; Haga, K.; Asaka, M.; Ramirez, F.; Yoshida, T. Downregulation and growth inhibitory effect of epithelial-type Krüppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem. Biophys Res. Commun., 2003, 308, 251-256.
87. Yasunaga, J.; Taniguchi, Y.; Nosaka, K.; Yoshida, M.; Satou, Y.; Sakai, T.; Mitsuya, H.; Matsuoka, M. Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res., 2004, 64, 6002-6009.
88. Kharas, M.G.; Yusuf, I.; Scarfone, V.M.; Yang, V.W.; Segre, J.A.; Huettner, C.S.; Fruman, D.A. KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood, 2007, 109, 747-755.
89. Schoenhals, M.; Kassambara, A.; De Vos, J.; Hose, D.; Moreaux, J.; Klein, B. Embryonic stem cell markers expression in cancers. Biochem. Biophys. Res. Commun., 2009, 383, 157-162.
90. Pandya, A.Y.; Talley, L.I.; Frost, A.R.; Fitzgerald, T.J.; Trivedi, V.; Chakravarthy, M.; Chhieng, D.C.; Grizzle, W.E.; Engler, J.A.; Krontiras, H.; Bland, K.I.; LoBuglio, A. F.; Lobo-Ruppert, S.M.; Ruppert, J.M. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin. Cancer Res., 2004, 10, 2709-2719.
91. Akaogi, K.; Nakajima, Y.; Ito, I.; Kawasaki, S.; Oie, S. H.; Murayama, A.; Kimura, K.; Yanagisawa, J. KLF4 suppresses estrogendependent breast cancer growth by inhibiting the transcriptional activity of ER . Oncogene, 2009, (Adv Online Pub).
92. Ghaleb, A.M.; McConnell, B.B.; Nandan, M.O.; Katz, J.P.; Kaestner, K.H.; Yang, V.W. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res., 2007, 67, 7147-7154.
93. Nandan, M.O.; Yoon, H.S.; Zhao, W.; Ouko, L.A.; Chanchevalap, S.; Yang, V. W. Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. Oncogene, 2004, 23, 3404-3413.
94. Kwak, M.K.; Lee, H.J.; Hur, K.; Park do, J.; Lee, H.S.; Kim, W.H.; Lee, K.U.; Choe, K.J.; Guilford, P.; Yang, H.K. Expression of Krüppel-like factor 5 in human gastric carcinomas. J. Cancer Res. Clin. Oncol., 2008, 134, 163-167.
95. Tong, D.; Czerwenka, K.; Heinze, G.; Ryffel, M.; Schuster, E.; Witt, A.; Leodolter, S.; Zeillinger, R. Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin. Cancer Res., 2006, 12, 2442-2448.
96. Chen, C.; Benjamin, M.S.; Sun, X.; Otto, K.B.; Guo, P.; Dong, X.Y.; Bao, Y.; Zhou, Z.; Cheng, X.; Simons, J.W.; Dong, J.T. KLF5 promotes cell proliferation and tumorigenesis through gene regulation and the TSU-Pr1 human bladder cancer cell line. Int. J. Cancer, 2006, 118, 1346-1355.
97. Giefing, M.; Wierzbicka, M.; Rydzanicz, M.; Cegla, R.; Kujawski, M.; Szyfter, K. Chromosomal gains and losses indicate oncogene and tumor suppressor gene candidates in salivary gland tumors. Neoplasma, 2008, 55, 55-60.
98. McConnell, B.B.; Bialkowska, A.B.; Nandan, M.O.; Ghaleb, A.M.; Gordon, F.J.; Yang, V.W. Haploinsufficiency of Krüppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res., 2009, 69, 4125-4133.